Intrauterine Contraceptive Devices Market (IUD/IUCD),by Type [Hormonal IUCD, Copper IUCD] – Global Forecast to 2019

The global intrauterine contraceptive devices market is segmented on the basis of type which includes hormonal IUCD and copper IUCD. The copper IUCD segment contributed for the maximum share of 51.9% in 2014, followed by hormonal IUCD with 48.1% share. On the basis of products, this market has been segmented into Mirena, Skyla, ParaGuard, and Essure. In terms of geography, the market covered regions, such as Asia, Europe, North America, and Rest of the World (ROW).

The growth of the intrauterine contraceptive devices market is driven by factors such as rising rate of unplanned pregnancies, effective contraception and minimum side effects of IUCD, implementation of Affordable Care Act (ACA), higher number of initiatives undertaken by private firms directed towards reducing the expenses related to abortion, and technological advancements. For instance, the Colorado Family Planning Initiative has provided more than 30,000 intrauterine devices (IUCDs) or implants at low or no cost to low-income women at 68 family planning clinics across Colorado since 2009. The decline in births among young women served by these agencies accounted for three-quarters of the overall decline in the Colorado teen birth rate. As a result, in July 2014, the organization announced that, the teen birth rate in Colorado dropped by 40% within 2009 to 2013, driven by a Colorado Department of Public Health and Environment initiative that helps low-income women get long-acting reversible contraceptives (LARC) such as intrauterine contraceptive devices. High cost of treatment, threat of causing pelvic inflammatory infection (PID), threat of causing ectopic pregnancy, high rate of complications during unplanned pregnancy, are hindering the growth of the IUCD market.

The report also provides a detailed competitive landscaping of companies operating in this market. Segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals and product recalls of the major companies are detailed in the report. The main companies operating in this market are Bayer HealthCare AG (A subsidiary of BAYER AG) (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis Plc. (Ireland), and Medicines360 (Ireland) and other companies.

Table of Contents

1 Introduction (Page No. - 8)
    1.1 Objectives of the Study
    1.2 Market Segmentation & Coverage

2 Research Methodology (Page No. - 11)
    2.1 Integrated Ecosystem of Intrauterine Contraceptive Devices Market
    2.2 Arriving at the Global Intrauterine Contraceptive Devices Market Size
           2.2.1 Top-Down Approach
           2.2.2 Bottom-Up Approach
           2.2.3 Macro Indicator-Based Approach
    2.3 Assumptions

3 Executive Summary (Page No. - 17)

4 Market Overview (Page No. - 19)
    4.1 Introduction
    4.2 Market Drivers and Inhibitors
    4.3 Key Market Dynamics

5 Global Intrauterine Contraceptive Devices Market, By Type (Page No. - 26)
    5.1 Introduction
    5.2 Copper Iud
    5.3 Hormonal Iud
    5.4 Global Intrauterine Contraceptive Devices Market, Type Comparison With Female Contraceptives Market
    5.5 Global Copper Iud Market, By Geography
    5.6 Global Hormonal Iud Market, By Geography

6 Global Intrauterine Contraceptive Devices Market,  By Product (Page No. - 33)
    6.1 Mirena
           6.1.1 Product Positioning and Promotions of Mirena
    6.2 Skyla
           6.2.1 Product Positioning and Promotions of Skyla
    6.3 Paragard
           6.3.1 Product Positioning and Promotions of Paragard
    6.4 Essure
           6.4.1 Product Positioning and Promotions of Essure
    6.5 Pipeline Products
           6.5.1 Levosert

7 Global Intrauterine Contraceptive Devices Market,  By Geography (Page No. - 41)
    7.1 Introduction
    7.2 Asia : Intrauterine Contraceptive Devices Market
    7.3 Europe : Intrauterine Contraceptive Devices Market, By Geography
    7.4 North America : Intrauterine Contraceptive Devices Market,  By Geography
    7.5 ROW Intrauterine Contraceptive Devices Market, By Geography

8 Global Intrauterine Contraceptive Devices Market: Competitive Landscape (Page No. - 59)
    8.1 Global Intrauterine Contraceptive Devices Market: Company Share Analysis
    8.2 Mergers & Acquisitions
    8.3 Regulatory Approvals
    8.4 Partnership
    8.5 Collaboration

9 Global Intrauterine Contraceptive Devices Market,  By Company (Page No. - 62)
(Overview, Financials, Products & Services, Strategy, and Developments)*
    9.1 Bayer Healthcare Ag (Subsidiary of Bayer Ag)
    9.2 Teva Pharmaceutical Industries Ltd.
    9.3 Actavis Plc
    9.4 Medicine360
    9.5 Trimedic Supply Network Ltd.
    9.6 Medisafe Distribution Inc.
    9.7 PACE Pharmaceuticals, Inc.
    9.8 SMB Corporation
    9.9 OCON Medical Ltd.
*Details on Overview, Financials, Product & Services, Strategy, and Developments Might Not be Captured in Case of Unlisted Company

10 Appendix (Page No. - 77)
     10.1 Related Reports
     10.2 Introducing RT: Real Time Market Intelligence
           10.2.1 RT Snapshots

List of Tables (26 Tables)

Table 1 Global Intrauterine Contraceptive Devices Market: Macro Indicators, By Region, 2008 (Abortion Per 1000 Women Ages 15-44)
Table 2 Global Intrauterine Contraceptive Devices Market: Drivers and Inhibitors
Table 3 Global Intrauterine Contraceptive Devices Market: Comparison With Global Female Contraceptives Market, 2013 - 2019 (USD MN)
Table 4 Global Intrauterine Contraceptive Devices Market, By Geography,2013 - 2019 (USD MN)
Table 5 Global Intrauterine Contraceptive Devices Market, By Type,2013 - 2019 (USD MN)
Table 6 Global Intrauterine Contraceptive Devices Market: Type Comparison With Female Contraceptives Market, 2013–2019 (USD MN)
Table 7 Global Copper Iud Market, By Geography, 2013 - 2019 (USD MN)
Table 8 Global Copper Iud Market, By Geography, 2013 - 2019 (USD MN)
Table 9 Global Intrauterine Contraceptive Devices Market, By Geography,2013 - 2019 (USD MN)
Table 10 Global Intrauterine Contraceptive Devices Market, By Type,2013 -2019 (USD MN)
Table 11 Asia :Intrauterine Contraceptive Devices Market, By Geography,2013-2019 (USD MN)
Table 12 Asia : Intrauterine Contraceptive Devices Market, By Type,2013-2019 (USD MN)
Table 13 Europe : Intrauterine Contraceptive Devices Market, By Geography,2013-2019 (USD MN)
Table 14 Europe : Intrauterine Contraceptive Devices Market, By Type
Table 15 North America : Intrauterine Contraceptive Devices Market,By Geography
Table 16 North America : Intrauterine Contraceptive Devices Market, By Type
Table 17 ROW Intrauterine Contraceptive Devices Market, By Geography
Table 18 ROW Intrauterine Contraceptive Devices Market, By Type
Table 19 Global Intrauterine Contraceptive Devices Market: Company Share Analysis, 2013 (%)
Table 20 Global Intrauterine Contraceptive Devices Market:Mergers & Acquisitions
Table 21 Global Intrauterine Contraceptive Devices Market: Regulatory Approvals
Table 22 Global Intrauterine Contraceptive Devices Market: Partnership
Table 23 Global Intrauterine Contraceptive Devices Market: Collaboration
Table 24 Bayer Healthcare Ag.: Key Financials, 2008 - 2013 (USD MN)
Table 25 Teva Pharmaceutical Industries Ltd.: Key Financials, 2008 - 2013 (USD MN)
Table 26 Actavis Plc: Key Financials, 2008 - 2013 (USD MN)

List of Figures (47 Figures)

Figure 1 Evolution of Intrauterine Contraceptive Devices (Iud/Iucd)
Figure 2 Global Intrauterine Contraceptive Devices Market:Segmentation & Coverage
Figure 3 Intrauterine Contraceptive Devices Market: Integrated Ecosystem
Figure 4 Top-Down Approach
Figure 5 Bottom-Up Approach
Figure 6 Macro Indicator-Based Approach
Figure 7 Global Intrauterine Contraceptive Devices Market Snapshot
Figure 8 Global Intrauterine Contraceptive Devices Market: Comparison With Global Female Contraceptives Market
Figure 9 Global Intrauterine Contraceptive Devices, By Region,2014 & 2019 (USD MN)
Figure 10 Global Intrauterine Contraceptive Devices Market, By Type,2014 & 2019 (USD MN)
Figure 11 Advantages & Disadvantages of Copper Iud
Figure 12 Advantages & Disadvantages of Hormonal Iud
Figure 13 Global Intrauterine Contraceptive Devices Market, By Type,2012 - 2018 (USD MN)
Figure 14 Global Intrauterine Contraceptive Devices Market: Type Comparison With Female Contraceptives Market, 2013–2019 (USD MN)
Figure 15 Global Copper Iud Market, By Geography , 2013 - 2019 (USD MN)
Figure 16 Global Hormonal Iud Market, By Geography, 2013 - 2019 (USD MN)
Figure 17 Adverse Effects Caused By Mirena, U.S., 1997-2012
Figure 18 Asia : Intrauterine Contraceptive Devices Market, By Geography
Figure 19 Asia : Intrauterine Contraceptive Devices Market, By Type
Figure 20 Asia: Intrauterine Contraceptive Devices Market, By Type
Figure 21 Asia : Intrauterine Contraceptive Devices Market: By Typecomparision With Female Contraceptive Devices Market (2013-2019)
Figure 22 Asia : Copper Intrauterine Contraceptive Devices Market, (2013-2019)
Figure 23 Asia: Hormonal Intrauterine Contraceptive Devices Market,  (2013-2019)
Figure 24 Europe : Intrauterine Contraceptive Devices Market, By Geography
Figure 25 Europe : Intrauterine Contraceptive Devices Market, By Type
Figure 26 Europe : Intrauterine Contraceptive Devices Market, By Types
Figure 27 Europe : Intrauterine Contraceptive Devices Market: By Type Comparison With Female Contraceptive Devices Market (2013-2019)
Figure 28 Europe : Copper Intrauterine Contraceptive Devices Market, (2013-2019)
Figure 29 Europe : Hormonal Intrauterine Contraceptive Devices Market,(2013-2019)
Figure 30 North America : Intrauterine Contraceptive Devices Market,By Geography
Figure 31 North America : Intrauterine Contraceptive Devices Market, By Types
Figure 32 North America : Intrauterine Contraceptive Devices Market, By Type
Figure 33 North America :Intrauterine Contraceptive Devices Market: By Types Comparison With Female Contraceptive Devices Market (2013-2019)
Figure 34 North America : Hormonal Intrauterine Contraceptive Devices Market, (2013-2019)
Figure 35 North America : Copper Intrauterine Contraceptive Devices Market,(2013-2019)
Figure 36 ROW Intrauterine Contraceptive Devices Market, By Geography
Figure 37 ROW Intrauterine Contraceptive Devices Market, By Type
Figure 38 ROW Intrauterine Contraceptive Devices Market, By Types
Figure 39 ROW Intrauterine Contraceptive Devices Market: By Types Comparison With Female Contraceptive Devices Market (2013-2019)
Figure 40 ROW Hormonal Intrauterine Contraceptive Devices Market, 2013-2019
Figure 41 ROW Copper Intrauterine Contraceptive Devices Market, (2013-2019)
Figure 42 Global Intrauterine Contraceptive Devices Market: Company Share Analysis, 2013 (%)
Figure 43 Bayer Healthcare Ag: Revenue Mix (2013) (%)
Figure 44 Contribution of Pharmaceuticals Segment Towards Company Revenues, 2008-2013 (USD MN)
Figure 45 Teva Pharmaceutical Industries Ltd.: Revenue Mix (2013) (%)
Figure 46 Contribution of Speciality Medicine Segment Towards Company Revenues, 2008-2013 (USD MN)
Figure 47 Actavis Plc: Revenue Mix (2013) (%)

Intrauterine contraceptive devices are most commonly known as IUD/IUCD. These devices are inserted into the uterus to prevent pregnancy. The IUCD can be a coil, loop, triangle, or T in shape made of plastic or metal. There are many types of IUCDs based on their shapes and sizes. They are usually made up of polypropylene saturated with barium sulfate, to visualize them on x-rays. The commonly used device is ’T’ shaped with a horizontal and vertical arm. The vertical arm has a copper wire wrapped around it and two colored nylon threads at the lower end. This thread (tail), which protrudes through the cervix into the vagina, enables the user to verify its correct placement. The hormone-releasing IUCDs available in the market are suitable for women with special needs. An IUCD is approximately 99.0% reliable in preventing pregnancy. The newer devices, such as Multi Loads ML-Cu-250, ML-Cu-375, and Cu 7 – 380 A, are highly effective, that is greater than 99.0% birth control assurance.

An IUCD is inserted into the uterus by a healthcare professional. This prevents sperms and egg from meeting by either immobilizing the sperms on their way to the fallopian tubes or by changing the uterine lining, so that the fertilized egg cannot implant in it.

There are two types of IUCDs approved in the worldwide, namely Copper and Hormonal IUCD. The hormonal IUCDs are of two types. The first is Progesterone IUCD (Progestasert), in which the vertical shaft of the IUCD is fitted with a capsule containing hormone progesterone, which is released in at a steady pace, giving the desired contraceptive effect. The life span of this type of IUCD is around 1 year. The other type is Levonorgestrel IUCD 20 (LNG 20, Lernova), in which the hormone, levonorgestrel is released. The life span for this device is between five and seven years.

The global intra-uterine contraceptive devices (IUCD) market was valued at $3,314.6 million in 2014, which is expected to reach a value of $4,605.6 million by 2019, at a CAGR of 6.8% from 2014 to 2019.

The copper IUCD market accounted for the maximum share of 51.9% in 2014, followed by hormonal IUCD with a share of 48.1%. The copper IUCD market is expected to reach $2,384.9 million by 2019, at a CAGR of 6.7%, and the hormonal IUCD market is expected to reach $2,222.0 million by 2019 at a CAGR of 6.9% from 2014 to 2019.

Geographically, the Asia contributed the maximum market share of around 35.0% in 2014. This market was valued at $1,161.3 million in 2014, and is expected to reach a value of $1,637.9 million by 2019, at a CAGR of 7.1% from 2014 to 2019. In terms of growth potential, the European market is an open market, and accounted for the second-largest market share of 30.1% in 2014. The European intrauterine contraceptive devices market was valued at $996.5 million in 2014, and is expected to reach $1,394.3 million by 2019, at a CAGR of 6.9% from 2014 to 2019.

The key players in the intrauterine contraceptive devices market are Bayer HealthCare AG (A subsidiary of BAYER AG) (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis plc (Ireland), Medicines360 (Ireland), Ocon Medical Ltd. (Israel), and SMB Corporation (India).